Canadian CANNAINVESTOR Magazine August / September 2019 | Page 154

Over time, alcohol could end up becoming taboo

Whatever marijuana’s health risks, it’s always going to be exponentially safer than Canada’s other legal party drug: alcohol. Alcohol puts more Canadians in the hospital every year than heart attacks. Alcohol is also a major contributor to virtually every violent crime imaginable. Half of all murderers had been drinking at the time of their offence, according to a 2014 meta-analysis. Roughly half of all sex assaults also involve alcohol in some form, according to U.S. stats. As social acceptance of pot increases — and as cannabis-infused drinks become more popular — it may start becoming gauche to show up to a party with whiskey or beer.

170

Alliance Cannabis Growers Corp

CSE:ACG OTC:ALGWF FWB:1LA

As At: August 2, 2019

Shares Issued and Outstanding: 86,106,361 (www.thecse.com)

Share Price: $0.045

Website: https://www.alliancegrowers.com/

projects in two locations. Both locations are situated close to the equator, both have the requisite sunshine and rainfall , tested and suitable soils, plus natural water readily available. Labour and taxes have been set in all our locations at the lowest levels seen globally, and logistics are secure and transparent.

Location, location, location. Canada is the world leader on many fronts and we know not only from our own past content but from various expert panels at the relevant conferences that locations situated close to the equator with requisite sunshine and rainfall and soil conditions should be the key to success for long term operations.

Our readers know all too well that we predicted just a few years ago that the US would start moving towards more liberal rules and regulations governing cannabis while some others were hoping perhaps in a decade if not longer. Seems now that not a day goes by without witnessing more progress on this front. Industrial Hemp of course is legal and ACG is all over this opportunity to be a dominant force in the US.

Although preliminary, ACG is in discussions with CROP Infrastructure Corp with respect to a partnership agreement whereby CROP’s subsidiary, Elite Ventures Group LLC, would grow the CBD rich proprietary hemp strain CBD Dana that ACG has access to it thanks to a prior astute partnership domestically. It is believed if this partnership comes to fruition that ACG’s gross revenues could be north of USD$26M.

A quick look at our standard metrics that suggest a company warrants further due diligence on the part of existing and prospective investors and where I believe ACG meets that threshold has a checkmark.

Business plan adept to this industry.

Diversification.

Management and team.

Strategic Partnerships.

International Expansion.

Multiple Market/Exchange listings.

Public float not dilutive.

Low market cap.

Executing their plans.

Proprietary products.

That is ten for ten within the context and parameters of ACG with respect to warranting further due diligence on your part. Always ensure your risk appetite and portfolio objectives are in line with any potential investment decision.

Personally, I cannot wait to see how their story unfolds and keep you apprised.

Disclosure: I have no positions in ACG mentioned, and no plans to initiate any position within 72 hours of publication date and time. I wrote this article myself, and it expresses my own opinions within the context to facilitate discussion to raise awareness only.

Disclaimer: The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation or advice to purchase/sell shares or to make any investment decision of any kind in ACG as well as any other investment. Before buying or selling this or any stock you should do your own research and reach your own conclusion – and/or consult a financial advisor.

Our readers know all too well that we predicted just a few years ago that the US would start moving towards more liberal rules and regulations governing cannabis while some others were hoping perhaps in a decade if not longer. Seems now that not a day goes by without witnessing more progress on this front. Industrial Hemp of course is legal and ACG is all over this opportunity to be a dominant force in the US.

Although preliminary, ACG is in discussions with CROP Infrastructure Corp with respect to a partnership agreement whereby CROP’s subsidiary, Elite Ventures Group LLC, would grow the CBD rich proprietary hemp strain CBD Dana that ACG has access to it thanks to a prior astute partnership domestically. It is believed if this partnership comes to fruition that ACG’s gross revenues could be north of USD$26M.

A quick look at our standard metrics that suggest a company warrants further due diligence on the part of existing and prospective investors and where I believe ACG meets that threshold has a checkmark.

Business plan adept to this industry.

Diversification.

Management and team.

Strategic Partnerships.

International Expansion.

Multiple Market/Exchange listings.

Public float not dilutive.

Low market cap.

Executing their plans.

Proprietary products.

That is ten for ten within the context and parameters of ACG with respect to warranting further due diligence on your part. Always ensure your risk appetite and portfolio objectives are in line with any potential investment decision.

Personally, I cannot wait to see how their story unfolds and keep you apprised.

Disclosure: I have no positions in ACG mentioned, and no plans to initiate any position within 72 hours of publication date and time. I wrote this article myself, and it expresses my own opinions within the context to facilitate discussion to raise awareness only.

Disclaimer: The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation or advice to purchase/sell shares or to make any investment decision of any kind in ACG as well as any other investment. Before buying or selling this or any stock you should do your own research and reach your own conclusion – and/or consult a financial advisor.

154